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htticense.Abstract Objectives: Many methods are included in the treatment of intractable epistaxis includ-
ing selective embolization. We report our experience with 10 patients treated with this technique.
Patients and methods: Ten patients with posterior idiopathic epistaxis were selected in this study.
They were managed by double-balloon device followed by embolization.
Results: Study included six males and four females, their age ranged from 49 to 66 years (mean
56 years). Four patients were hypertensive, two were smokers. Epistaxis was unilateral in six
patients and bilateral in four. Six internal maxillary and eight sphenopalatine arteries were embol-
ized with polyvinyl alcohol 150–250 lm. Bleeding stopped in all patients after procedure. One
patient had recurrent attack 2 months later for whom re-embolization successfully stopped bleed-
ing. No major complications encountered but minor complications occurred in two patients (one
severe headache and one transient left temporofacial pain).
Conclusion: Selective embolization is a clinically effective treatment for severe refractory posterior
epistaxis. By this method we can avoid the complications of repeated packs and surgery especially in
elderly patients.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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SPA, sphenopalatine artery;
(A.H. Abou-Issa).
tian Society of Radiology and
g by Elsevier
Radiology and Nuclear Medicine.
p://dx.doi.org/10.1016/j.ejrnm.20121. Introduction
Epistaxis or nasal bleeding has been reported to occur in up to
60% of general population (1–3). Six percent requires emer-
gent medical attention (4,5). About 70% of epistaxis is idio-
pathic (5–7). Hypertension, hypercholesterolemia, cigarette
smoke, alcohol abuse, acetylsalicylic acid and other anti-
inﬂammatory analgesic medications (NSAIDs) and anatomic
defects in nasal septum are predisposing factors (1,8). Struc-
tural causes include trauma, tumor, vascular abnormalities
and bleeding diathesis (9).Production and hosting by Elsevier B.V. All rights reserved.
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ior nasal packing and the use of local vasoconstrictors. For
refractory epistaxis, surgical or endovascular procedures may
be indicated (10). Patients with posterior epistaxis of internal
maxillary artery origin that failed conservative measures have
been suggested as excellent candidates for angiographic embo-
lization (11). The literature for angiographic embolization ex-
tends back to 1974 when Sokoloff and others ﬁrst described
the use of this technique in two patients with refractory epi-
staxis. Since that time, numerous case series have been re-
ported (12,13).
This article outlines our experience with angiographic
embolization for the treatment of refractory posterior
epistaxis.2. Patients and methods
Ten patients with idiopathic posterior epistaxis were selected
after complete history taking, general and local examinations
and complete investigations. Epistaxis was initially managed
by packing the nose with double-balloon device for 2 days.
In these patients, epistaxis was persistent therefore they were
offered the option of embolization.
The double-balloon device was advanced into the affected
nostril until reaches the nasopharynx (Fig. 1). The posterior
balloon was inﬂated with 7–10 ml saline and the catheter
extending out of the nostril is withdrawn carefully so that
the balloon seats in the posterior nasal cavity to tamponade
the bleeding source. The anterior balloon is then inﬂated with
roughly 15–30 ml saline in the anterior nasal cavity to prevent
retrograde travel of the posterior balloon and subsequent air-
way obstruction. The balloon packs are left in place for 2 days.
After 2 days, the pressure decreased to the middle of the in-
ﬂated amount and epistaxis was continued in all patients, then
the balloon is re-inﬂated and the patients were referred to
interventional radiology unit for angiographic embolization.
The procedure and possible complications were explained
to patients, written informed consent then obtained. Emboliza-
tion was done using biplane DSA machine, Siemens Axiom
Artis. Under local anesthesia with 10–15 ml lidocaine hydro-
chloride 1%, the right common femoral artery was punctured
and a 5F sheath introduced. In all patients, selective external &
internal carotid angiography was done with 5F headhunter1
catheter to help localize the source of bleeding and to exclude
possible anastomosis to the carotid siphon or ophthalmic ar-
tery to avoid the complications of stroke or blindness. AFig. 1 (A) Deﬂated and inﬂated double-balloon nasal catheter. (B) D
(13).microcatheter (Renegade HI-FLO, 2.8F Boston Scientiﬁc)
was advanced into the artery of interest to embolize the culprit
feeders. The catheter tip was positioned in SPA (eight arteries)
or in the most distal part of IMA (six arteries) to avoid embo-
lization of arteries with high potential for dangerous anasto-
mosis, such as the middle meningeal, accessory meningeal,
and superﬁcial temporal arteries (Fig. 2). Polyvinyl alcohol
particles, 150–250 lm (Contour, Boston Scientiﬁc) were in-
jected slowly and under intermittent ﬂuoroscopic control to
avoid reﬂux into non target arteries and to monitor occlusion
of the nasal vessels. Control angiography was performed after
embolization to assess the results.
If angiography fails to demonstrate any active bleeding
with the balloon in place, the pressure of the balloon was re-
duced to half to help detection of the bleeding site by noting
contrast pooling. If no active bleeding noted, then the SPA/
IMA was embolized. The balloon is re-inﬂated and kept in
place for 1 day, removed on 2nd post-procedure day, and then
patient was discharged on 3rd day. The follow-up period for
all patients was 4 months.
3. Results
Six males and four females with a mean age of 56 years (49–66)
were included in this study. Four patients were hypertensive
and two were smokers. Epistaxis was unilateral in six patients
and bilateral in four. Embolization of six IMAs and eight
SPAs was done. Bleeding stopped in all patients after proce-
dure. One patient had recurrent attack of epistaxis 2 months
later for whom re-embolization was done. Complications re-
ported in our series were severe headache in one patient and
transient left temporofacial pain in another one patient which
lasted 2 days (Table 1).
This patient had previous history of left IMA clipping
(Fig. 3). She has perforated nasal septum which mandated
LT ICA angiography to exclude bleeding from left ethmoidal
branches which could pass through perforated septum to exit
from right nostril.
4. Discussion
Management of epistaxis can be very difﬁcult specially when
there is posterior bleeding. Treatment options include chemical
cautery, anterior & posterior nasal packing, septoplasty with
bilateral ﬂap elevation, internal maxillary artery ligation, and
external carotid artery or anterior ethmoidal artery ligation.iagram shows expected locations of the balloons within nasal cavity
Fig. 2 Fifty YOM presented with bilateral idiopathic epistaxis refractory to packing. (A) Angiography in AP projection through a
microcatheter in IMA (arrow) shows abnormal vascularity along septal and lateral nasal walls. (B) Microcatheter advanced into SPA
prior to embolization with PVA 150–250 lm. (C) Post-embolization angiography shows no residual vascular blush. (D and E) Left
internal maxillary angiography in AP & Lat projections show nasal hypervascularity. Microcatheter tip was advanced in most distal part
of IMA (not shown). (F) Control angiography conﬁrmed absence of vascular blush. Bleeding stopped after procedure.
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52% (3,14). Posterior nasal packing is associated with consid-
erable discomfort, mucosal trauma and morbidity due to hy-
poxia (15). Traditional arterial ligation methods are
associated with signiﬁcant morbidity and failure rates. The
transantral approach to the maxillary artery may cause dam-
age to the nasolacrimal duct or infra-orbital nerve and thus
cheek anesthesia (3,16). External carotid artery ligation is asso-
ciated with a risk of damage to hypoglossal and vagus nerves.
Moreover, there is high failure rate due to extensive anastomo-
sis distal to the site of ligation (15).Recent management of epistaxis includes angiography and
embolization of the bleeding vessels. Management requires an
experienced interventional radiologist which is not available in
many centers. Moreover, this procedure may be associated
with serious neurological complications (17,18). Angiography
and selective embolization are less invasive and faster than
open arterial ligation (19). Its advantage is that it offers more
distal access to bleeding points, avoids the need for general
anesthesia, requires a shorter time for the procedure and al-
lows preservation of other branches of external carotid artery
(20). There was an increasing number of embolization done for
Table 1 Presentation, embolization side and complications in 10 cases.
Age Sex Predisposing Epistaxis Embolization Complications
49 F – Left Unilateral SPA Temporofacial pain
52 M HTN Bilateral Bilateral IMA –
49 M HTN Bilateral IMA+ contralateral SPA –
51 M Smoking Left Unilateral SPA –
52 F – Right Unilateral SPA –
54 M – Bilateral IMA+ contralateral SPA –
61 F HTN Left Unilateral SPA –
63 M Smoking Left Unilateral SPA –
65 F – Right Unilateral IMA+ Severe headache
66 M HTN Bilateral IMA+ contralateral SPA –
Fig. 3 Sixty-ﬁve YOF presented with intractable RT epistaxis and perforated nasal septum. Left internal maxillary artery was clipped
10 years ago. (A) RT ECA angiography, lateral view shows abnormal nasal vessels and contrast pooling (arrows). (B) After embolization,
note microcatheter tip at distal IMA (arrow). (C) Left ICA angiography in lateral projection conﬁrmed absence of bleeding from left
ethmoidal branches.
410 Y. Haroon et al.posterior epistaxis in recent years whereas the number of liga-
tions remains fairly constant. Poor surgical candidates with
multisystem disease, prolonged intensive care stays because
of multiple medical problems and patient preference to avoid
surgical procedure were possible explanation for the increase
of embolization (21).
We used double-balloon device system in managing poster-
ior epistaxis as it was effective and less complicated than the
packing procedure. Angiography in the presence of nasal pack-
ing was not very effective in determining the exact site of bleed-
ing (22). With the balloon device, pressure can be decreased
and site of bleeding can be detected on angiography.
Complications related to embolization include cerebrovas-
cular accidents, hemiplegia, blindness, facial nerve palsy, sei-zures and soft tissue necrosis, the overall complication rate
in published reports is around 3–27% (20). The majority of
complications reported was minor and transient (19). Other
complications encountered included septal perforation, sinusi-
tis, facial numbness and otitis media (7,23–25). None of these
complications were noted in our patients except left temporo-
facial pain in one patient which lasted for 2 days and severe
headache in another case.
Rebleeding occurred in one patient after 2 months for
whom re-embolization of the bleeding side successfully con-
trolled it. Nathan et al. (13) reported in their series that 13%
has recurrence and was controlled with surgical interference.
In our series, we embolized the symptomatic side only, no fa-
cial artery embolization was performed in any case, and the
Embolization for control of refractory posterior epistaxis 411recurrence rate was 10% (1 case). Other authors (10) have
shown that the success rate can be increased to over 95% if tri-
lateral (bilateral IMA and ipsilateral facial artery) emboliza-
tion is performed as a preemptive measure to prevent
recurrence. However we did not perform this technique to re-
duce procedure time and complication risk.
5. Conclusion
Angiographic embolization is considered a safe and effective
method in the management of refractory posterior epistaxis
with 100% initial control rate. It should be considered in the
treatment options of posterior epistaxis if technical expertise
is available.
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